Comparative incidence of immune-related adverse events and hyperprogressive disease in patients with non-small cell lung cancer receiving immune checkpoint inhibitors with and without chemotherapy.
Invest New Drugs
; 39(4): 1150-1158, 2021 08.
Article
en En
| MEDLINE
| ID: mdl-33483882
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Protocolos de Quimioterapia Combinada Antineoplásica
/
Carcinoma de Pulmón de Células no Pequeñas
/
Inhibidores de Puntos de Control Inmunológico
/
Neoplasias Pulmonares
Tipo de estudio:
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Invest New Drugs
Año:
2021
Tipo del documento:
Article